Position history for SANDS CAPITAL MANAGEMENT, LLC's holdings in ULTRAGENYX PHARMACEUTICAL IN
SANDS CAPITAL MANAGEMENT, LLC holds 3.5M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $80.2M as of 2025-Q4. The position was decreased (-7.5% shares). RARE represents 0.2% of SANDS CAPITAL MANAGEMENT, LLC's portfolio.
Current Value
$80.2M
Current Shares
3.5M
Total Value Change
-$139.9M
Total Shares Change
-1.9M
Other major holders of RARE: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 3.5M |
-7.5% |
| $80.2M |
| 0.2% |
| $22.78 |
0 |
| 2025-Q3 | Decreased | 3.8M | -4.4% | $113.4M | 0.3% | $30.36 | 0 |
| 2025-Q2 | Decreased | 3.9M | -5.3% | $143.4M | 0.4% | $36.52 | 0 |
| 2025-Q1 | Decreased | 4.2M | -3.1% | $150.8M | 0.5% | $37.82 | 0 |
| 2024-Q4 | Decreased | 4.3M | -16.0% | $180.8M | 0.5% | $42.27 | 0 |
| 2024-Q3 | Decreased | 5.1M | -4.4% | $284.3M | 0.9% | $54.43 | 0 |
| 2024-Q2 | Increased | 5.4M | +38.7% | $220.1M | 0.6% | $41.10 | 57 |